Events, By Category and Date:
» Go to news mainReinstitutionalizing transparency at Health Canada
Posted by nte on
December 24, 2015
in
In Print
Matthew Herder. [PDF 192 KB - Open Access].Canadian Medical Association Journal (Early release, published at www.cmaj.ca. 22 Dec 2015).
See from Matthew Herder on this topic.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize